Neurotech International Limited (ASX:NTI)

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Revenue	0	0	0.01	0.04	0.21
Other Revenue	2.58	3.18	1.19	0.57	0
Revenue	2.58	3.18	1.19	0.61	0.21
Revenue Growth (YoY)	-18.75%	166.00%	96.58%	194.44%	156.86%
Cost of Revenue	-	0.01	-	0.03	-0.02
Gross Profit	2.58	3.17	1.19	0.57	0.23
Selling, General & Admin	2.01	3.51	2.58	1.35	2.31
Research & Development	9.94	5.25	6.45	2.58	5.36
Other Operating Expenses	-0.35	-0.36	0.02	0.01	0
Operating Expenses	13.18	8.4	9.05	3.93	7.67
Operating Income	-10.6	-5.23	-7.85	-3.36	-7.45
Interest Expense	-	-	-	-0	-0
Interest & Investment Income	-	0.16	0.06	0	0
Other Non Operating Income (Expenses)	-	-	-	-	0.02
EBT Excluding Unusual Items	-10.6	-5.07	-7.79	-3.36	-7.43
Pretax Income	-10.6	-5.07	-7.79	-3.36	-7.43
Net Income	-10.6	-5.07	-7.79	-3.36	-7.43
Net Income to Common	-10.6	-5.07	-7.79	-3.36	-7.43
Shares Outstanding (Basic)	1,039	912	799	697	493
Shares Outstanding (Diluted)	1,039	912	799	697	493
Shares Change (YoY)	13.94%	14.17%	14.56%	41.54%	218.70%
EPS (Basic)	-0.01	-0.01	-0.01	-0.00	-0.02
EPS (Diluted)	-0.01	-0.01	-0.01	-0.00	-0.02
Free Cash Flow	-9.02	-4.6	-6.32	-2.96	-2.32
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.00	-0.01
Gross Margin	100.00%	99.75%	100.00%	94.40%	109.86%
Operating Margin	-410.57%	-164.52%	-657.31%	-553.20%	-3609.23%
Profit Margin	-410.57%	-159.54%	-652.33%	-553.35%	-3600.70%
Free Cash Flow Margin	-349.57%	-144.63%	-528.84%	-486.88%	-1122.53%
EBITDA	-10.6	-5.23	-7.85	-3.36	-
EBITDA Margin	-	-164.50%	-	-	-
D&A For EBITDA	0	0	0	0	-
EBIT	-10.6	-5.23	-7.85	-3.36	-7.45
EBIT Margin	-	-164.52%	-	-	-
Advertising Expenses	0	0	0.01	0.01	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.